Telix Pharmaceuticals Aktie

Kaufen

Verkaufen

9,20 EUR +0,20 EUR +2,22 %

18:52:20

FSE

10,84 USD +0,18 USD +1,69 %

21:59:55

BTT

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Div. Rendite0,00%

WKNA40FCQ

ISINUS87961M1053

SymbolTLX

Telix Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

12.01.25PR NewswireTelix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

30.12.24PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

29.12.24PR NewswireTelix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

19.12.24PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

28.11.24PR NewswireFirst Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

19.11.24PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline

18.11.24PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline

13.11.24PR NewswireTelix and Eckert & Ziegler to Partner on Actinium-225 Production Technology

03.11.24PR NewswireTelix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals

30.10.24PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

24.10.24PR NewswireFDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

22.10.24PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

17.10.24PR NewswireTelix Files Form 20-F Registration Statement for Nasdaq ADS

17.10.24PR NewswireTelix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M

16.10.24PR NewswireTelix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

07.10.24PR NewswireAustralian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy

03.10.24PR NewswireFirst Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery

23.09.24PR NewswireTelix to Acquire RLS to Expand North American Manufacturing and Distribution Platform

17.09.24PR NewswireTelix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®

11.09.24PR Newswire'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

04.09.24PR NewswireIPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

28.08.24PR NewswireTelix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

27.08.24PR NewswireTelix Announces Reorganisation to Deliver on Strategic Priorities

22.08.24PR NewswireTelix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities

24.07.24PR NewswireFDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

24.07.24PR NewswireTelix Successfully Prices A$650 Million Convertible Bonds

23.07.24PR NewswireTelix Announces A$600 Million Convertible Bonds Offering

18.07.24PR NewswireTelix Pharmaceuticals Q2 2024 Revenue and Business Highlights, Guidance Upgrade

11.07.24PR NewswireTelix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals

Telix Pharmaceuticals News

Telix Pharmaceuticals News: auf dieser Seite finden Sie alle Telix Pharmaceuticals News und Nachrichten zur Telix Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Telix Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Telix Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.